לינפארזה 50 מג
astra zeneca (israel) ltd - olaparib - קפסולה קשיחה - olaparib 50 mg - olaparib
מקיניסט 0.5 מג
novartis israel ltd - trametinib as dimethyl sulfoxide - טבליות מצופות פילם - trametinib as dimethyl sulfoxide 0.5 mg - trametinib
מקיניסט 2 מג
novartis israel ltd - trametinib as dimethyl sulfoxide - טבליות מצופות פילם - trametinib as dimethyl sulfoxide 2 mg - trametinib
קיטרודה 100 מג4 מל
merck sharp & dohme (israel - 1996) company ltd, israel - pembrolizumab - תרכיז להכנת תמיסה לאינפוזיה - pembrolizumab 25 mg/ml - pembrolizumab
פירמגון 120 מג
ferring pharmaceuticals ltd - degarelix as acetate - אבקה וממס להכנת תמיסה להזרקה - degarelix as acetate 120 mg - degarelix - degarelix - for the treatment of adult male patients with advanced hormone-dependent prostate cancer.
פירמגון 80 מג
ferring pharmaceuticals ltd - degarelix as acetate - אבקה וממס להכנת תמיסה להזרקה - degarelix as acetate 80 mg - degarelix - degarelix - for the treatment of adult male patients with advanced hormone-dependent prostate cancer.
locator
cortex dental implants industries ltd. - רופא שיניים - חיבור בן המבנה לתותבת
baha - hearing aids and implants for rehabilitation of hearing
טרדיס גת בע"מ - כלל האוכלוסיה - לליקוי שמיעה הולכתי, מעורב או חירשות חד צדית
פרזיסטה 75 מג
j-c health care ltd - darunavir as ethanolate - טבליות מצופות פילם - darunavir as ethanolate 75 mg - darunavir - darunavir - adult patients : prezista, co-administered with ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv -1) infection. this indication is based on analyses of plasma hiv rna levels and cd4+ cell counts from 2 controlled phase 3 trials of 48 weeks duration in antiretroviral treatment - naive and treatment -experienced patients and 2 controlled phase 2 trials of 96 weeks duration in clinically advanced, treatment -experienced adult patients .pediatric patients :prezista, co-administered with ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of hiv in pediatric patients 6 years of age and older. this indication is based on week 24 analyses of plasma hiv rna levels and cd4+ cell counts from an open-label phase 2 trial in antiretroviral treatment -experienced pediatric patients 6 to < 18 years of age. in treatment-experienced adult and pediatric the following points should be considered when ini
פרזיסטה 150 מג
j-c health care ltd - darunavir as ethanolate - טבליות מצופות פילם - darunavir as ethanolate 150 mg - darunavir - darunavir - adult patients : prezista, co-administered with ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv -1) infection. this indication is based on analyses of plasma hiv rna levels and cd4+ cell counts from 2 controlled phase 3 trials of 48 weeks duration in antiretroviral treatment - naive and treatment -experienced patients and 2 controlled phase 2 trials of 96 weeks duration in clinically advanced, treatment -experienced adult patients .pediatric patients :prezista, co-administered with ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of hiv in pediatric patients 6 years of age and older. this indication is based on week 24 analyses of plasma hiv rna levels and cd4+ cell counts from an open-label phase 2 trial in antiretroviral treatment -experienced pediatric patients 6 to < 18 years of age. in treatment-experienced adult and pediatric the following points should be considered when ini